UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β‑Lactamases

Journal of medicinal chemistry, 2020-11, Vol.63 (21), p.12511-12525

2020

Volltextzugriff (PDF)

Rational design of a new antibiotic class for drug-resistant infections

Nature (London), 2021-09, Vol.597 (7878), p.698-702

2021

Volltextzugriff (PDF)

Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class

Journal of medicinal chemistry, 1998-08, Vol.41 (18), p.3467-3476

1998

Volltextzugriff (PDF)

Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design

Journal of medicinal chemistry, 2001-12, Vol.44 (26), p.4524-4534

2001

Volltextzugriff (PDF)

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Nature microbiology, 2017-06, Vol.2 (9), p.17104, Article 17104

2017

Volltextzugriff (PDF)

Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors

Bioorganic & medicinal chemistry, 2011-08, Vol.19 (15), p.4626-4634

2011

Volltextzugriff (PDF)

N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay

Bioorganic & medicinal chemistry, 2020-12, Vol.28 (24), p.115826-115826, Article 115826

2020

Volltextzugriff (PDF)

Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13

Journal of medicinal chemistry, 2009-06, Vol.52 (11), p.3523-3538

2009

Volltextzugriff (PDF)

Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13

Bioorganic & medicinal chemistry letters, 2011-11, Vol.21 (21), p.6440-6445

2011

Volltextzugriff (PDF)

N-Arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B

Bioorganic & medicinal chemistry letters, 2003-11, Vol.13 (22), p.4121-4124

2003

Volltextzugriff (PDF)

Structure-Based Design of HIV Protease Inhibitors: Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors

Journal of medicinal chemistry, 1996-10, Vol.39 (22), p.4349-4353

1996

Volltextzugriff (PDF)

Non-peptidic HIV protease inhibitors : C2-SYMMETRY-BASED design of bis-sulfonamide dihydropyrones

Bioorganic & medicinal chemistry letters, 1998-05, Vol.8 (10), p.1237-1242

1998

Volltextzugriff (PDF)

Novel synthesis of heterocyclic aryl amidines

Tetrahedron letters, 1998-08, Vol.39 (33), p.5947-5950

1998

Volltextzugriff (PDF)

Total synthesis of (-)-(9R)-7,11-dideoxy-13-deoxodaunomycinone

Journal of organic chemistry, 1991-09, Vol.56 (20), p.5758-5759

1991

Volltextzugriff (PDF)

Structure-Based Design of HIV Protease Inhibitors: 5,6-Dihydro-4-hydroxy-2-pyrones as Effective, Nonpeptidic Inhibitors

Journal of medicinal chemistry, 1996-11, Vol.39 (23), p.4630-4642

1996

Volltextzugriff (PDF)

AutoChem: Automated Solution-Phase Parallel Synthesis and Purification via HPLC

Journal of combinatorial chemistry, 2000-09, Vol.2 (5), p.447-449

2000

Volltextzugriff (PDF)

Immobilizations of Nucleophiles on Polystyrene Supports

Synlett, 1998-08, Vol.1998 (8), p.906-908

1998

Volltextzugriff (PDF)

Non-peptidic HIV protease inhibitors: C 2-symmetry-based design of bis-sulfonamide dihydropyrones

Bioorganic & medicinal chemistry letters, 1998-05, Vol.8 (10), p.1237-1242

1998

Volltextzugriff (PDF)

Covalent or trapped? PFG diffusion MAS NMR for combinatorial chemistry

Tetrahedron letters, 1999-08, Vol.40 (34), p.6141-6143

1999

Volltextzugriff (PDF)

Novel method for the loading of nucleophiles on multipin crowns

Tetrahedron letters, 1998-07, Vol.39 (31), p.5477-5480

1998

Volltextzugriff (PDF)

Enantioselective syntheses of anthracyclinones

Tommasi, Ruben A

1992

Volltextzugriff (PDF)

ESKAPEing the labyrinth of antibacterial discovery

Nature reviews. Drug discovery, 2015-08, Vol.14 (8), p.529-542

2015

Volltextzugriff (PDF)

Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens

Journal of medicinal chemistry, 2014-12, Vol.57 (23), p.10144-10161

2014

Volltextzugriff (PDF)

In vivo dose response and efficacy of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against the Acinetobacter baumannii-calcoaceticus complex

Antimicrobial agents and chemotherapy, 2024-01, Vol.68 (1), p.e0080023-e0080023

2024

Volltextzugriff (PDF)

Antibacterial Drug Discovery: Some Assembly Required

ACS infectious diseases, 2018-05, Vol.4 (5), p.686-695

2018

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(57)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(32)
Pharmacology & Pharmacy
(28)
Chemistry, Medicinal
(24)
Animals
(17)
Physical Sciences
(17)
Chemistry
(16)
Chemistry, Organic
(13)
Humans
(13)
Structure-Activity Relationship
(13)
Biological And Medical Sciences
(11)
Drug Design
(11)
Medical Sciences
(10)
Microbial Sensitivity Tests
(10)
Pharmacology. Drug Treatments
(10)
Anti-Bacterial Agents - Pharmacology
(9)
Models, Molecular
(9)
Rats
(9)
Crystallography, X-Ray
(8)
Mice
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β‑Lactamases

Rational design of a new antibiotic class for drug-resistant infections

Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class

Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors

N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay

Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13

Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13

N-Arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B

Structure-Based Design of HIV Protease Inhibitors: Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors

Non-peptidic HIV protease inhibitors : C2-SYMMETRY-BASED design of bis-sulfonamide dihydropyrones

Novel synthesis of heterocyclic aryl amidines

Total synthesis of (-)-(9R)-7,11-dideoxy-13-deoxodaunomycinone

Structure-Based Design of HIV Protease Inhibitors: 5,6-Dihydro-4-hydroxy-2-pyrones as Effective, Nonpeptidic Inhibitors

AutoChem: Automated Solution-Phase Parallel Synthesis and Purification via HPLC

Immobilizations of Nucleophiles on Polystyrene Supports

Non-peptidic HIV protease inhibitors: C 2-symmetry-based design of bis-sulfonamide dihydropyrones

Covalent or trapped? PFG diffusion MAS NMR for combinatorial chemistry

Novel method for the loading of nucleophiles on multipin crowns

Enantioselective syntheses of anthracyclinones

ESKAPEing the labyrinth of antibacterial discovery

Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens

In vivo dose response and efficacy of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against the Acinetobacter baumannii-calcoaceticus complex

Antibacterial Drug Discovery: Some Assembly Required

Suchergebnisse filtern